Comparative analysis of clinical, morphological and prognostic parameters of non-metastatic skin melanoma

Modern understanding of melanoma carcinogenesis and progression highlights the importance of identifying risk factors and prognosis at early stages.
Purpose of the study. Analysis of clinical characteristics in patients with skin melanoma.
Patients and methods. A retrospective analysis of the medical records of 142 patients with skin melanoma has been carried out. Data on age, gender, tumor localization, disease stage according to the American Joint Committee on Cancer (8th ed., 2017), histological types according to the WHO classification (2022), as well as treatment methods and disease outcomes have been analyzed.
Results. Among the studied patients with skin melanoma, women predominated – 78 cases (54.9 %), men – 64 cases (45.1 %). The average age of patients was 63 ± 5.6 years, ranging from 29 to 88 years. Melanoma was most frequently diagnosed at advanced stages: stages IIIA–IIID were detected in 53 patients (37.3 %), stages IIA–IIC – in 40 (28.2 %), and stages 0 and IA–IB – in 16 (11.3 %) and 33 (23.2 %) patients, respectively. The predominant histological types were nodular melanoma (48.6 %) and superficially spreading melanoma (38.7 %). The most common tumor localizations were the skin of the lower extremities (32.3 %) and the back (30.9 %). In 23 patients (16.2 %) with disease progression, metastases were detected in the brain, lymph nodes, liver, lungs, and bones.
Conclusions. The carried-out analysis can help clarify the clinical and morphological features of skin melanoma and improve diagnostic and therapeutic approaches.

1. World Health Organization (WHO). (2020). Skin cancers. Available at: https://www.who.int/news-room/fact-sheets/detail/skin-cancers. Accessed 26.05.2025.

2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394–424. https://doi.org/10.3322/caac.21492 Erratum in: CA Cancer J Clin. 2020 Jul;70(4):313. https://doi.org/10.3322/caac.21609

3. Conforti C, Zalaudek I. Epidemiology and Risk Factors of Melanoma: A Review. Dermatol Pract Concept. 2021 Jul 1;11(Suppl 1):e2021161S. https://doi.org/10.5826/dpc.11s1a161s

4. Kazubskaya ТP, Mekheda LV, Trofimov EI, Fomina LYa, Kharkevich GYu, T.S. Belysheva TS, et al. Melanoma, molecular and genetic aspects of etiopathogenesis: classification, epidemiology, risk factors, braf and nras mutations. Voprosy Onkologii. 2022;68(6):725–732. (In Russ.). https://doi.org/10.37469/0507-3758-2022-68-6-725-732

5. Kwa M, Ravi M, Elhage K, Schultz L, Lim HW. The risk of ultraviolet exposure for melanoma in Fitzpatrick skin types I-IV: A 20-year systematic review with meta-analysis for sunburns. J Eur Acad Dermatol Venereol. 2024 Sep 4. https://doi.org/10.1111/jdv.20316

6. Kiran A, Narayanasamy N, Ramesh JVN, Ahmad MW. A novel deep learning framework for accurate melanoma diagnosis integrating imaging and genomic data for improved patient outcomes. Skin Res Technol. 2024 Jun;30(6):e13770. https://doi.org/10.1111/srt.13770

7. Neretin EYu, Kozlov SV, Zolotareva TG. Medical and organizational approaches to early diagnosis of skin melanoma. Health care of the Russian Federation. 2021;65(6):557–564. (In Russ.). https://doi.org/10.47470/0044-197x-2021-65-6-557-564

8. Malignant neoplasms in Russia in 2023 (morbidity and mortality). Edited by Kaprin AD, Starinsky VV, Shakhzadova AO. Мoscow: P. Hertsen Moscow Oncology Research Institute – Branch of the National Medical Radiology Research Centre of the Ministry of Health of the Russian Federation, 2024, 276 p. Available at: https://oncology-association.ru/wp-content/uploads/2024/08/ zis-2023-elektronnaya-versiya.pdf. Accessed: 26.05.2025.

9. Dzwierzynski WW. Melanoma Risk Factors and Prevention. Clin Plast Surg. 2021 Oct;48(4):543–550. https://doi.org/10.1016/j.cps.2021.05.001

10. Nazzaro G, Passoni E, Pozzessere F, Maronese CA, Marzano AV. Dermoscopy Use Leads to Earlier Cutaneous Melanoma Diagnosis in Terms of Invasiveness and Size? A Single-Center, Retrospective Experience. J Clin Med. 2022 Aug 21;11(16):4912. https://doi.org/10.3390/jcm11164912

11. Garbe C, Keim U, Amaral T, Berking C, Eigentler TK, Flatz L, et al. Prognosis of Patients With Primary Melanoma Stage I and II According to American Joint Committee on Cancer Version 8 Validated in Two Independent Cohorts: Implications for Adjuvant Treatment. J Clin Oncol. 2022 Nov 10;40(32):3741–3749. https://doi.org/10.1200/jco.22.00202

12. Gronbeck C, Kerr PE. Nodular melanoma. Clin Dermatol. 2025 Jan-Feb;43(1):64–70. https://doi.org/10.1016/j.clindermatol.2025.01.015

13. Farahmand AM, Ehsani AH, Mirzaei M, Mohsenian M, Ghanadan A. Patients' Characteristics, Histopathological Findings, and Tumor Stage in Different Types of Malignant Melanoma: A Retrospective Multicenter Study. Acta Med Iran. 2017 May;55(5):316–323.

14. Palacios Diaz RD, de Unamuno Bustos B, Pozuelo Ruiz M, Llavador Ros M, Palanca Suela S, Botella Estrada R. Study of Microsatellite Instability by Immunohistochemistry in a Cohort of Patients With Melanoma. J Cutan Pathol. 2025 Feb;52(2):162–171. https://doi.org/10.1111/cup.14758

15. Wagner NB, Knierim SM, Luttermann F, Metzler G, Yazdi AS, Bauer J, et al. Histopathologic regression in patients with primary cutaneous melanoma undergoing sentinel lymph node biopsy is associated with favorable survival and, after metastasis, with improved progression-free survival on immune checkpoint inhibitor therapy: A single-institutional cohort study. J Am Acad Dermatol. 2024 Apr;90(4):739–748. https://doi.org/10.1016/j.jaad.2023.11.040

16. Bainvoll L, Mandelbaum RS, Worswick SD, Matsuo K. Anatomical location of melanoma: A gender-specific analysis. J Surg Oncol. 2023 Jan;127(1):203–206. https://doi.org/10.1002/jso.27111

17. Wee E, Wolfe R, Mclean C, Kelly JW, Pan Y. The anatomic distribution of cutaneous melanoma: A detailed study of 5141 lesions. Australas J Dermatol. 2020 May;61(2):125–133. https://doi.org/10.1111/ajd.13223

18. Ministry of Health of the Russian Federation. Clinical Guidelines «Melanoma of the Skin and Mucous Membranes». Мoscow, 2023. Available at: https://oncology-association.ru/wp-content/uploads/2023/11/melanoma_kozhi_i_slizistyh_obolochek_2023.pdf. Accessed: 26.05.2025.

19. Robert C, Grob JJ, Stroyakovskiy D, Karaszewska B, Hauschild A, Levchenko E, et al. Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma. N Engl J Med. 2019 Aug 15;381(7):626–636. https://doi.org/10.1056/nejmoa1904059